Skip to Content

News

Akadeum Advances Platform Toward Cell Therapy Applications, New Data Revealed at Biotech Showcase and Development-Stage Automated Instrument Previewing at Advanced Therapies Week

Updated on Oct 10, 2023

The company that pioneered microbubbles for cell isolation and activation shares new data and capabilities, demonstrating impactful advancements for cell and gene therapy applications ANN ARBOR, Mich., Jan. 17, 2023 — Akadeum Life Sciences Inc., a global leader in buoyancy-based cell separation technology, announced today that it will preview its automated platform at Phacilitate’s Advanced Therapies Week, January 17-20th in Miami, Florida. At Advanced Therapies Week, Akadeum will also share early adopter …

Akadeum Life Sciences Launches First of its Kind Product Benefitting Cell and Gene Therapy Research Following Successful Data from Early Access Program

Updated on Mar 9, 2023

Positive Results Spurs Launch of Akadeum’s Leukopak Isolation Kit citing speed, scalability, and cell recovery among prized attributes from biospecimen providers and cell and gene therapy developers ANN ARBOR, Mich., Dec. 21, 2022 — Akadeum Life Sciences, Inc., a global leader in buoyancy-based cell separation technology, announces their Microbubble Leukopak Human T Cell Isolation research-use-only kit that resulted from successful external user data with early adopters. Akadeum’s T cell isolation …

Immune Control and Evasion During Acute and Chronic HBV Infection

Published on Nov 18, 2022

Investigating the role of T cell exhaustion and T cell memory in hepatitis B virus infections Dr. Hannah Drescher, a Postdoctoral Research Fellow in Professor Georg Lauer’s lab at Mass Gen Hospital and Harvard Medical School, used Akadeum’s Human CD4+ T Cell Isolation Kit with BACS™ Microbubbles to isolate cells to study the role of T cells during acute and chronic HBV infection. Specifically, Hannah is interested in studying the …

Cloning Mouse B Cells for Antibody Production Using Akadeum’s Novel High-Throughput Mouse B Cell Isolation Microbubbles

Published on Nov 18, 2022

Cloning Mouse B Cells for Antibody Production Using Akadeum’s Novel High-Throughput Mouse B Cell Isolation Microbubbles

In a Head-to-Head Comparison Akadeum’s Mouse B Cell Isolation Microbubbles Generated 32% More Positive Antigen-Specific Antibodies Compared to Magnetic-Based Procedures Abbratech compared Akadeum’s novel Mouse B Cell Isolation Kit with buoyancy-activated cell sorting (BACSTM) microbubbles to a negative selection magnetics-based kit for isolation of B cells from fresh splenocytes to determine which process would be incorporated into their mouse B cell cloning workflow. After enrichment, samples were cultured under various …

Putting People First for Meaningful Innovation

Updated on Mar 6, 2023

Brandon McNaughton

This article by Akadeum’s CEO Dr. Brandon H. McNaughton was originally published in CEOWorld Magazine. The secret to a truly great organization is the values and beliefs that exist at its core. Since the founding of Akadeum Life Sciences in 2014, the standards we uphold are to diligently help people solve problems in their lab work around separating cells, nucleic acids, or proteins from biological samples. This separation step is …

Akadeum Life Sciences Announces Early-Access Launch of Large-Scale Cell Isolation Kit for Leukopaks

Updated on Apr 25, 2023

Akadeum’s microbubble technology allows scientists to effortlessly process up to twice as many leukopaks in as little as one-third the time of traditional methods, increasing throughput and optimizing processes ANN ARBOR, Mich., Sept. 21, 2022 — Akadeum Life Sciences, Inc., a global leader in buoyancy-based cell separation technology, announces a new early access program launch of an industry-first: the Microbubble Leukopak Human T Cell Isolation Kit. This new research use-only kit …

Akadeum Life Sciences Announces New Dead Cell Removal Kit Using Microbubble Technology

Published on Aug 25, 2022

This new buoyant separation method creates a more effective way for researchers to use valuable samples with a higher retention rate of viable cells than current magnetic techniques Ann Arbor, MI – August 4, 2022 – Akadeum Life Sciences, Inc.—a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and molecular research for human health and life sciences—announces today the launch of their Dead Cell Removal …

Akadeum Granted Patent for Buoyancy-Based Cell Separation “Microbubble” Technology

Updated on Oct 10, 2023

The patent bolsters Akadeum’s intellectual property and protects its current and future roster of buoyant separation products and applications ANN ARBOR, Mich., June 20, 2022 — Akadeum Life Sciences, Inc., a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and molecular research for human health and life sciences, today announces a patent issuance for its proprietary method of buoyancy-based cell sorting (BACS ™) technologies from biological fluid …

Akadeum Unveils Cell Separation Product Expansion at American Association of Immunologist Meeting

Updated on Apr 4, 2023

Human B Cell Isolation Kit graphic

Akadeum to showcase high-purity, high-yield isolation of Human B cells without the need for a column or magnet ANN ARBOR, Mich., May 06, 2022 — Akadeum Life Sciences, Inc.—a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics and cell and molecular research for human health and life sciences—today announced the expansion of its cell separation product portfolio with a new human B cell isolation product and updated …

Akadeum’s First Rising Innovators Research Award Recipient

Published on Dec 14, 2021

Akadeum is thrilled to announce the first recipient of the Rising Innovators Research Award! Congratulations to Giselle Borges e Soares from Dr. Katherine Wall’s Laboratory at the University of Toledo. Giselle used Akadeum’s Mouse CD4+ T Cell Isolation Kit in the course of her research, obtaining 95-97% purity with ease. The success of downstream experiments is dependent upon the quality of the CD4+ T cell fraction, and by using Akadeum’s …

Back to Top